Skip to Main Content

Advertisement

Skip Nav Destination

FDA Approval Summary: Tremelimumab in Combination with Durvalumab for the Treatment of Patients with Unresectable Hepatocellular Carcinoma

Clin Cancer Res (2024) 30 (2): 269–273.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Pavlina Spiliopoulou
  • Paramjit Kaur
  • Tracey Hammett
  • Giusy Di Conza
  • Michael Lahn
Cancer Drug Resistance (2024)
  • Ting Yan
  • Lun Yu
  • Jiwen Zhang
  • Yun Chen
  • Yilan Fu
  • Jingyi Tang
  • Dehua Liao
Frontiers in Immunology (2024) 15
  • Huimin Zou
  • Ying Ge
  • Wenge Chen
  • Dongning Yao
  • Carolina Oi Lam Ung
  • Yunfeng Lai
  • Hao Hu
International Immunopharmacology (2024) 132: 111947.
  • Erica Silvestris
  • Stella D’Oronzo
  • Easter Anna Petracca
  • Claudia D’Addario
  • Gennaro Cormio
  • Vera Loizzi
  • Stefano Canosa
  • Giacomo Corrado
Journal of Personalized Medicine (2024) 14 (4): 431.
  • Trevor Kwan-Hung Wu
  • Rex Wan-Hin Hui
  • Lung-Yi Mak
  • James Fung
  • Wai-Kay Seto
  • Man-Fung Yuen
F1000Research (2024) 13: 104.
Close Modal

or Create an Account

Close Modal
Close Modal